Status:

UNKNOWN

Exercise, Prediabetes and Diabetes After Renal Transplantation.

Lead Sponsor:

Hospital Universitario de Canarias

Collaborating Sponsors:

Instituto de Salud Carlos III

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18-110 years

Phase:

NA

Brief Summary

This study is designed to evaluate the feasibility of exercise to reverse prediabetes after transplantation to prevent Posttransplantation Diabetes Mellitus (PTDM).

Detailed Description

The hypothesis of the study is that exercise will promote the reversibility to normal glucose metabolism in patients with prediabetes and eventually reduce the incidence of PTDM in renal transplant. T...

Eligibility Criteria

Inclusion

  • Age \> 18 years old.
  • Renal transplantation: beyond 6-12 months after transplantation with stable renal function
  • IFG: 100-125 mg/dl and IGT 140-199 mg/dl.
  • Ability or capacity to perform exercise.

Exclusion

  • Clinical conditions that preclude the treatment with exercise i.e. clinical instability: active infection, cancer, acute cardiovascular disease, advanced renal disease, pulmonar hypertension, chronic obstructive pulmonary disease, severe reumatological disorders, arthrosis, arthritis limb amputation, etc.
  • Inability to understand the protocol.
  • Severe psychological disease.
  • PTDM.
  • Diabetes before transplantation.

Key Trial Info

Start Date :

September 5 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04489043

Start Date

September 5 2019

End Date

October 1 2021

Last Update

July 28 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UICEC

San Cristóbal de La Laguna, S/C de TEnerife, Spain, 38320